Generation Bio Co.
GBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $21,451 | $27,136 | $70,743 |
| - Cash | $21,940 | $49,094 | $50,891 | $76,301 |
| + Debt | $19,744 | $85,324 | $87,577 | $93,560 |
| Enterprise Value | – | $57,681 | $63,822 | $88,002 |
| Revenue | $1,594 | $765 | $8,723 | $4,188 |
| % Growth | 108.4% | -91.2% | 108.3% | – |
| Gross Profit | $190 | $765 | $8,723 | $4,188 |
| % Margin | 11.9% | 100% | 100% | 100% |
| EBITDA | -$4,116 | -$21,268 | -$14,332 | -$18,786 |
| % Margin | -258.2% | -2,780.1% | -164.3% | -448.6% |
| Net Income | -$5,520 | -$20,923 | -$14,802 | -$21,382 |
| % Margin | -346.3% | -2,735% | -169.7% | -510.6% |
| EPS Diluted | -0.82 | -3.12 | -2.21 | -3.2 |
| % Growth | 73.7% | -41.2% | 30.9% | – |
| Operating Cash Flow | -$52,680 | -$16,828 | -$28,360 | -$15,784 |
| Capital Expenditures | $0 | -$459 | -$246 | -$378 |
| Free Cash Flow | -$52,680 | -$17,287 | -$28,606 | -$16,162 |